Antimicrobial Stewardship Programs in Pediatric Intensive Care Units: A Systematic Scoping Review

Cecilia Liberati1, Giulia Brigadoi1, Elisa Barbieri1

  • 1Division of Paediatric Infectious Diseases, Department of Women's and Children's Health, University of Padova, 35128 Padua, Italy.

PubMed

Insights

Antimicrobial stewardship programs (ASPs) in pediatric intensive care units (PICUs) show promise but lack standardized metrics. Harmonizing reporting is crucial for comparing effectiveness and improving antimicrobial use in critically ill children.

Area of Science:

  • Pediatric Critical Care Medicine
  • Infectious Diseases
  • Healthcare Management

Background:

  • Antimicrobial stewardship programs (ASPs) and diagnostic stewardship programs (DSPs) are critical for combating antimicrobial resistance.
  • Implementation of these programs in pediatric intensive care units (PICUs) is essential but may face unique challenges.

Purpose of the Study:

  • To review and summarize the current implementation status of ASPs and DSPs specifically within PICUs.
  • To identify common strategies, outcomes, and challenges associated with these stewardship programs in pediatric critical care settings.

Main Methods:

  • A systematic literature search was conducted across major databases (Embase, MEDLINE, Scopus, Cochrane Library) from 2007 to 2024.
  • Studies evaluating ASP or DSP implementation in PICUs were included, with data extracted using standardized forms.
  • Included references were managed and screened using Rayyan software.

Main Results:

  • 18 studies were included: 13 focused on ASPs and 5 on DSPs.
  • Most ASP studies reported positive effects on antimicrobial consumption, often using persuasive strategies.
  • Significant heterogeneity in intervention types, outcome metrics, and study designs was observed, limiting direct comparisons.
  • DSP studies primarily examined biomarkers and pathogen testing, with limited impact on antibiotic prescribing.

Conclusions:

  • ASP implementation in PICUs is ongoing but remains limited, with considerable variability in outcome measurement.
  • Harmonizing reporting metrics is essential for comparing program effectiveness and optimizing antimicrobial stewardship strategies in PICUs.
  • Further research is needed to establish best practices for diagnostic stewardship in pediatric critical care.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...